Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00128986
Status:
COMPLETED
Last Update Posted:
2016-04-06
First Post:
2005-08-09
Brief Title:
Study of Tomotherapy in Patients With Benign Brain Tumour
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Although malignant brain tumors are the most common type of primary brain tumor there are a number of other benign brain tumors that exist Many difficulties exist with treating these tumors that have led to controversies in the best treatment A common issue among these brain tumors is the risk of long term side effects from treatment What limits the use of curative radiation therapy is the ability to deliver a maximal dose to the tumor while minimizing the amount of radiation to the normal structures in the brain A new method of delivering radiation called tomotherapy has been acquired at the Cross Cancer Institute CCI and will be used in this study It has the ability to deliver a high dose of radiation to the tumor while minimizing the amount of radiation to normal brain structures This study will use this method of radiation therapy to deliver radiation and see if the long term side effects from radiation therapy can be reduced
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None